Israeli Lab-Grown Kidney Startup Seeks China Funding
“`html
sheba Medical Center Seeks Funding to Advance lab-Grown Kidney Trials
Table of Contents
Sheba Medical Centre in tel Aviv, Israel, is actively seeking funding, including potential investment from China, to move forward with clinical trials of kidneys cultivated in a laboratory setting. This progress, led by project lead Dekel, represents a important step towards addressing the global organ shortage.
Dekel is now focused on translating lab success into medical treatments.
The Global Organ Shortage and the Promise of Lab-Grown Organs
The demand for organ transplantation far exceeds the available supply worldwide.According to the organ Procurement and transplantation Network (OPTN), over 100,000 people in the United States alone are currently waiting for an organ transplant. Thousands die each year while waiting. This shortage drives research into alternative solutions, including the development of bioengineered organs.
Cultivating organs in the lab, also known as tissue engineering, offers the potential to eliminate the waitlist and reduce the risk of organ rejection. The process typically involves using a scaffold, often derived from a donor organ, and seeding it with the patient’s own cells. This minimizes the immune response and the need for lifelong immunosuppressant drugs.
Sheba Medical Centre’s Breakthrough
While details of Sheba Medical Centre’s specific technique are currently limited, the prosperous cultivation of a functional kidney in the lab represents a major achievement. The ability to create a viable kidney, even in a preliminary stage, demonstrates the feasibility of this approach. Further research will focus on scaling up the process and ensuring the long-term functionality of the lab-grown organs.
The pursuit of funding, including from China, highlights the international interest in this technology. China has been actively investing in biomedical research and development, and a partnership with Sheba Medical Centre could accelerate the translation of this breakthrough into clinical practice.